Clinical Trials Browser

Phase 3 × Has results × atezolizumab × Clear all

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

Lung Neoplasms

Esophageal Neoplasms

Small Cell Lung Carcinoma

Carcinoma, Transitional Cell

Carcinoma, Hepatocellular

Carcinoma, Renal Cell

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

Small Cell Lung Carcinoma

Carcinoma, Hepatocellular

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Prostatic Neoplasms, Castration-Resistant

Urologic Neoplasms

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases, Triple Negative Breast Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Triple Negative Breast Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Renal Cell

Small Cell Lung Carcinoma

Carcinoma, Transitional Cell

Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Carcinoma, Renal Cell

Triple Negative Breast Neoplasms

Squamous Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Non-Squamous Non-Small Cell Lung Cancer

Colorectal Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)

SKYSCRAPER-08

SKYSCRAPER-02

IMAGINE

IMbrave050

CONTACT-03

IMforte

SKYSCRAPER-02C

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer

EL1SSAR

CONTACT-01

CONTACT-02

COSMIC-312

A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

IMpassion132

AMETHISTA

KATE3

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

KEYVIBE-008

A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

IMvigor130

IMpassion050

IPSOS

IMpassion030

IMbassador250

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

IMpassion131

A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)

IMpassion031

IMbrave150

IMmotion010

IMpower133

IMvigor010

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

IMagyn050

IMmotion151

A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]

IMpower150

IMpower130

OAK

A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370)

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)